Peter Attia

I don't think anyone would consider that destiny.

Of those, would you say that the latter is the most important, that it's the alternative fuel source that is the most important?

Let's go back to, I haven't paid any attention to this, what's happening in clinical trials?

This is a much easier thing to test.

Has someone done the experiment where you take people in the earliest stages of dementia or in modest stages of MCI, mild cognitive impairment, who are progressing towards dementia and

and you randomize them to standard of care versus the exact same standard of care plus a KD.

Has that experiment been done cleanly in a randomized fashion?

Those experiments, like many things, are ongoing.

So patient selection is going to matter.

And what do you think is the state of the art with alpha GPC just in general for normal cognitive enhancement?

All right, let's talk a little bit about hyperbaric oxygen.

Now, you mentioned and alluded to the fact that there are a handful of FDA indications for them.

To me, the two most apparent would be treatment of the bends and obviously for burn patients, so it dramatically aids with wound healing.

But there are many things that are conspicuously absent from any FDA approval.

There's no FDA approval for TBI.

There's no FDA approval for concussion.

There's no FDA approval for anything geroprotective.

And yet, I've always said, every time I've gone back, and I maybe do this every two years, I go back and look at the data around concussion and TBI.

It depends how you look at the data.

There could be a case for it.